Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib is a research paper published in Hepatology (2017). On theSindex it has a DataRank of 0.557. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.557
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
2.81
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study
Additional file 1 of Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study